EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults — United States, December 2020–March 2023

Juan Carlos C Montoy, James Ford, Huihui Yu, Michael Gottlieb, Dana Morse, Michelle Santangelo, Kelli N O'Laughlin, Kevin Schaeffer, Pamela Logan, Kristin Rising, Mandy J Hill, Lauren E Wisk und 15 weitere

MMWR. Morbidity and Mortality Weekly Report · 11.08.2023 · 72 (32) · 859-865

DOI: 10.15585/mmwr.mm7232a2 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, online erschienen am 11.08.2023. Verfasst von Juan Carlos C Montoy und 26 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To further the understanding of post-COVID conditions, and provide a more nuanced description of symptom progression, resolution, emergence, and reemergence after SARS-CoV-2 infection or COVID-like illness, analysts examined data from the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE), a prospective multicenter cohort study. This report includes analysis of data on self-reported symptoms collected from 1,296 adults with COVID-like illness who were tested for SARS-CoV-2 using a Food and Drug Administration-approved polymerase chain reaction or antigen test at the time of enrollment and reported symptoms at 3-month intervals for 12 months. Prevalence of any symptom decreased substantially between baseline and the 3-month follow-up, from 98.4% to 48.2% for persons who received a positive SARS-CoV-2 test results (COVID test-positive participants) and from 88.2% to 36.6% for persons who received negative SARS-CoV-2 test results (COVID test-negative participants). Persistent symptoms decreased through 12 months; no difference between the groups was observed at 12 months (prevalence among COVID test-positive and COVID test-negative participants = 18.3% and 16.1%, respectively; p>0.05). Both groups reported symptoms that emerged or reemerged at 6, 9, and 12 months. Thus, these symptoms are not unique to COVID-19 or to post-COVID conditions. Awareness that symptoms might persist for up to 12 months, and that many symptoms might emerge or reemerge in the year after COVID-like illness, can assist health care providers in understanding the clinical signs and symptoms associated with post-COVID-like conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AdultHumansAcute DiseaseCohort StudiesCOVID-19 TestingPost-Acute COVID-19 SyndromePrevalenceProspective StudiesSARS-CoV-2United States

Zitieren

APA

Montoy, J. C. C., Ford, J., Yu, H., Gottlieb, M., Morse, D., Santangelo, M., O'Laughlin, K. N., Schaeffer, K., Logan, P., Rising, K., Hill, M. J., Wisk, L. E., Salah, W., Idris, A. H., Huebinger, R. M., Spatz, E. S., Rodriguez, R. M., Klabbers, R. E., Gatling, K., …, & Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group (2023). Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults — United States, December 2020–March 2023. MMWR. Morbidity and Mortality Weekly Report, 72(32), 859-865. https://doi.org/10.15585/mmwr.mm7232a2

Vancouver

Montoy JCC, Ford J, Yu H, Gottlieb M, Morse D, Santangelo M, et al. Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults — United States, December 2020–March 2023. MMWR. Morbidity and Mortality Weekly Report. 2023;72(32):859-865. doi:10.15585/mmwr.mm7232a2

BibTeX
@article{Montoy2023,
  author = {Montoy, Juan Carlos C and Ford, James and Yu, Huihui and Gottlieb, Michael and Morse, Dana and Santangelo, Michelle and O'Laughlin, Kelli N and Schaeffer, Kevin and Logan, Pamela and Rising, Kristin and Hill, Mandy J and Wisk, Lauren E and Salah, Wafah and Idris, Ahamed H and Huebinger, Ryan M and Spatz, Erica S and Rodriguez, Robert M and Klabbers, Robin E and Gatling, Kristyn and Wang, Ralph C and Elmore, Joann G and McDonald, Samuel A and Stephens, Kari A and Weinstein, Robert A and Venkatesh, Arjun K and Saydah, Sharon and Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group, Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group},
  title = {Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults — United States, December 2020–March 2023},
  journal = {MMWR. Morbidity and Mortality Weekly Report},
  year = {2023},
  volume = {72},
  number = {32},
  pages = {859--865},
  doi = {10.15585/mmwr.mm7232a2}
}
Kostenlos starten →